Corporate investor

Eli Lilly and Company

Compiled from public sources

Eli Lilly and Company, founded in 1876 and headquartered in Indianapolis, Indiana, is a global pharmaceutical corporation. The company focuses on the discovery, development, manufacturing, and marketing of pharmaceutical products across various therapeutic areas, including neuroscience, endocrinology, oncology, and immunology. As part of its investment strategy, Eli Lilly engages in venture capital investments, allocating funds to early and growth-stage biotech firms to enhance its research and development pipeline. The company is also a member of the Biotechnology Innovation Organization (BIO), reflecting its commitment to fostering innovation in biotechnology.